GLP-1R signaling does not modify the severity of experimental graft versus host disease.

A similar trend was observed in those receiving C57BL/6 GLP-1R KO cells, although the reduction did not reach statistical significance relative to syngeneic controls ( Figure 4 D).

also in 111,027 other papers